Literature DB >> 2578420

Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia.

K Borch, H Renvall, G Liedberg.   

Abstract

Endoscopic screening in 123 patients with pernicious anemia (PA) yielded 4 patients with solitary and 1 patient with multiple gastric carcinoid tumors. Quantitative histologic studies of multiple standardized biopsy specimens showed a significantly increased number of fundic mucosal argyrophil endocrine cells in 40 patients with PA when compared with 15 patients with simple fundic atrophic gastritis (p = 0.002) or 8 normal controls (p = 0.0001). Patients with simple atrophic gastritis had increased numbers of fundic mucosal argyrophil cells as compared with normal controls (p = 0.02). A significant difference was also noticed in the number of antral mucosal argyrophil cells between patients with PA and normal controls (p = 0.01), but not between patients with PA and patients with simple atrophic gastritis. It is concluded that, in addition to having hyperplasia of gastric mucosal argyrophil endocrine cells, patients with PA run an increased risk of developing gastric argyrophil cell carcinoid tumors, which should be regarded as potentially malignant.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578420     DOI: 10.1016/0016-5085(85)90131-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  78 in total

1.  Calbindin immunoreactivity is a characteristic of enterochromaffin-like cells (ECL cells) of the human stomach.

Authors:  J B Furness; R T Padbury; K G Baimbridge; J M Skinner; D E Lawson
Journal:  Histochemistry       Date:  1989

2.  U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.

Authors:  J E Valenzuela; R G Berlin; W J Snape; T L Johnson; B I Hirschowitz; J Colon-Pagan; R S Morse; J Petrozza; G M Van Deventer; A Cagliola
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Omeprazole.

Authors:  M J Langman
Journal:  BMJ       Date:  1991-08-31

4.  Distinct metaplastic and inflammatory phenotypes in autoimmune and adenocarcinoma-associated chronic atrophic gastritis.

Authors:  Sangho Jeong; Eunyoung Choi; Christine P Petersen; Joseph T Roland; Alessandro Federico; Rossana Ippolito; Francesco P D'Armiento; Gerardo Nardone; Osamu Nagano; Hideyuki Saya; Marco Romano; James R Goldenring
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

5.  Fasting gastric pH and its relationship to true hypochlorhydria in humans.

Authors:  M Feldman; C Barnett
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

6.  Omeprazole: gastrin and gastric data (August 1991)

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

7.  Long term omeprazole therapy for reflux esophagitis:follow-up in serum gastrin levels,EC cell hyperplasia and neoplasia.

Authors:  Pankaj Singh; Anant Indaram; Ronald Greenberg; Vernu Visvalingam; Simmy Bank
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 8.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

9.  Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.

Authors:  Melanie L Richards; Paul Gauger; Norman W Thompson; Thomas J Giordano
Journal:  World J Surg       Date:  2004-06-16       Impact factor: 3.352

10.  Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.

Authors:  G E Feurle
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.